Experiment 990473
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Catharanthus roseus (APOCYNACEAE) |
| Citation | REYNOLDS,TF: VUGRIN,D: CVITKOVIC,E: GRALLA,RJ: YOUNG,CW: GOLBEY,RB:. (1979). PHASE II TRIAL VINDESINE IN PATIENTS WITH GERM-CELL TUMORS.. 63() |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE II CLINICAL TRIAL INVOLVING 20 SUBJECTS WITH TESTICULAR GERM CELL TUMORS:19 WERE EVALUABLE AFTER ONE FULL COURSE OF TREATMENT THE DOSE LIMITING TOXIC EFFECT WAS LEUKOPENIA:IT WAS SEEN IN ALL OF THE 19 SUBJECTS THE DRUG WAS WELL TOLERATED:6/19 PATIENTS HAD NO COMPLAINTS ATTRIBUTABLE TO VINDESINE 9/19 HAD PARESTHESIAS:6/19 HAD CONSTIPATION:6/19 HAD FEVER AND 6/19 HAD MUCOSITIS |
| Dose amount | 1.3 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Gender | MALE |